Previous 10 | Next 10 |
2023-09-11 09:15:17 ET More on Palisade Bio Financial information for Palisade Bio Palisade stock rallies as high as 180% on IBD drug licensing deal Palisade Bio fails in mid-stage trial for lead asset For further details see: Palisade Bio drops 6%, names...
Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies for acute an...
2023-09-07 10:54:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Asensus Surgical (NYSEMKT: ASXC ) stock is rising higher on Thursday as investors react to news of a collaboration with Nvidia (NASDAQ: NVDA ). The big a...
2023-09-07 10:28:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Palisade Bio (NASDAQ: PALI ) stock is falling on Thursday after the clinical-stage biopharmaceutical company announced a share offering . Palisade Bio is selling over 2....
2023-09-07 09:13:05 ET More on Palisade Bio Seeking Alpha’s Quant Rating on Palisade Bio Historical earnings data for Palisade Bio Financial information for Palisade Bio Palisade stock rallies as high as 180% on IBD drug licensing deal Palisade...
2023-09-07 08:43:42 ET Losers: NeuBase Therapeutics ( NBSE ) -25% . Sportsman's Warehouse Holdings ( SPWH ) -23% after Q2 earning release . Palisade Bio ( PALI ) -19% . Yext ( YEXT ) -16% after Q2 earning release . Verint Systems...
Carlsbad, CA, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is announcing today that it has entered into definitive agreements with institutional investors...
2023-09-07 06:10:00 ET 3 Top Tools to Use to Analyze Penny Stocks Penny stocks, often priced below $5 per share, present a unique opportunity for investors looking to diversify their portfolios and tap into the potential of emerging companies. Trading penny stocks has gained signifi...
2023-09-06 12:53:35 ET Gainers: NeuBase Therapeutics ( NBSE ) +124% . Palisade Bio ( PALI ) +113% . Power REIT ( PW ) +45% . AeroVironment ( AVAV ) +26% . Theratechnologies ( THTX ) +27% . iCoreConnect ( ICCT ) +20% ....
2023-09-06 12:31:59 ET More on Palisade Bio Seeking Alpha’s Quant Rating on Palisade Bio Historical earnings data for Palisade Bio Financial information for Palisade Bio Palisade Bio fails in mid-stage trial for lead asset For further details s...
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...